Season 1 Episode 196
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Lisa Shea, director of global patient advocacy and engagement for immunology at Johnson & Johnson, about the experiences of patients affected by HDFN and FNAIT.
Published on 2 months ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate